A highly sensitive real-time PCR-based in vitro diagnostic assay for the quantitative detection of Hepatitis B Virus (HBV) DNA in clinical specimens including plasma and serum. Designed to support early diagnosis, disease monitoring, and antiviral treatment response assessment with precision and reliability.
Hepatitis B Virus (HBV) is a double-stranded DNA virus that infects the liver and can cause both acute and chronic hepatitis. Chronic HBV infection affects more than 296 million people worldwide and is a leading cause of cirrhosis, liver failure, and hepatocellular carcinoma.
HBV is transmitted through contact with infected blood, sexual contact, and from mother to child at birth. Accurate quantification of HBV DNA viral load is essential for diagnosis, staging of liver disease, guiding antiviral therapy decisions, and monitoring treatment efficacy.
The Genplex™ HBV RT-PCR Kit provides reliable quantitative results, validated on major RT-PCR platforms including ThermaCyte X16 & X96 and most open RT-PCR instruments. An Internal Control (IC) is included in every reaction to ensure result validity.
Advanced molecular diagnostic capabilities engineered for clinical excellence and research-grade precision.
Accurate quantification of HBV DNA viral load in plasma and serum for clinical decision-making.
Designed to detect HBV DNA at clinically relevant thresholds with high diagnostic accuracy.
Covers low to high viral load concentrations, supporting both initial diagnosis and monitoring.
Four calibrated quantification standards (QS1–QS4) for reliable standard curve generation.
Validated on ThermaCyte X16 & X96 (Probgen) and most open RT-PCR instruments.
Built-in IC in every reaction validates extraction efficiency and detects inhibition.
Designed for diverse diagnostic and research use cases across the clinical spectrum.
Monitor HBV DNA levels to guide antiviral therapy initiation, modification, and discontinuation.
Screen blood donations to prevent transfusion-transmitted HBV infections.
Assess virological response to antiviral therapy over time using quantitative HBV DNA measurement.
Population-level tracking of HBV prevalence and disease burden in endemic regions.
| Parameter | Value / Description |
|---|---|
| Target Pathogen | Hepatitis B Virus (HBV) DNA |
| Assay Type | Singleplex Quantitative PCR |
| Sample Type | Plasma, Serum |
| Sensitivity | High Sensitivity |
| Internal Control | Included in every reaction |
| Standards | 4 Quantification Standards (QS1–QS4) |
| Compatible Instruments | ThermaCyte X16, ThermaCyte X96, and most open RT-PCR platforms |
| Intended Use | In Vitro Diagnostic (IVD) |
| Storage | -20°C |
For in vitro diagnostic use. Contact your regional distributor or ProbGen representative to place an order.
| Product Name | Cat. No. | Pack Size |
|---|---|---|
| Genplex™ Hepatitis B Virus (HBV) RT-PCR KIT | GP1038 | 48 tests |
| Genplex™ Hepatitis B Virus (HBV) RT-PCR KIT | GP1039 | 96 tests |
Contact our scientific team for technical specifications, bulk pricing, or to request a demonstration of our diagnostics solutions.
Contact Us All Products